| Donald L Kimpel, | |
|
415 Ray C. Hunt Dr, Ste 2100, Charlottesville, VA 22903 | |
| (434) 243-0223 | |
| (434) 244-7584 |
| Full Name | Donald L Kimpel |
|---|---|
| Gender | Male |
| Speciality | Rheumatology |
| Experience | 38 Years |
| Location | 415 Ray C. Hunt Dr, Charlottesville, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700955325 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | 0101235294 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Virginia Medical Center | Charlottesville, VA | Hospital |
| Novant Health Uva Health System Culpeper Med Cente | Culpeper, VA | Hospital |
| Centra Health - Lynchburg Gen Hospital | Lynchburg, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Virginia Physicians Group | 4880590728 | 1397 |
News Archive
NicOx S.A. today announced that a New Drug Application (NDA) for naproxcinod has been submitted to the United States Food and Drug Administration (FDA), seeking approval for an indication for the relief of the signs and symptoms of osteoarthritis (OA). The NDA file contains data from three large pivotal phase 3 studies, all of which met their co-primary efficacy endpoints. NicOx plans to submit a Marketing Authorization Application (MAA) for naproxcinod to the European Medicines Agency (EMEA) in Q4 2009.
TapeBeat.com, the news and research portal for the serious bio-tech investor in conjunction with the Farseers Group is proud to profile one of the most exciting up and coming biotech companies, MedaSorb Technologies (MSBT.OB), which is perfectly poised to realize exponential growth.
Doctors and clinical investigators from the throughout the Middle East gathered today in Dubai for the opening of the International Osteoporosis Foundation's (IOF) 1st Middle-East and Africa Osteoporosis Meeting.
Memory lapses that occur with normal aging are a source of worry for many who fear Alzheimer's disease. Now a new Mayo Clinic-led study published in the July 16 issue of the New England Journal of Medicine suggests that the carriers of a common genetic risk factor for Alzheimer's disease begin to have memory declines in their mid-50s, far earlier than previously thought.
HMS today announced that it had been awarded two cost containment contracts by the Idaho Department of Health and Welfare, which administers Idaho's Medicaid program. Under the first contract, HMS will to identify third party coverage for casualty and liability claims paid by Idaho Medicaid, and pursue recoveries.
› Verified 4 days ago
| Entity Name | University Of Virginia Physicians Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033138250 PECOS PAC ID: 4880590728 Enrollment ID: O20040102000780 |
News Archive
NicOx S.A. today announced that a New Drug Application (NDA) for naproxcinod has been submitted to the United States Food and Drug Administration (FDA), seeking approval for an indication for the relief of the signs and symptoms of osteoarthritis (OA). The NDA file contains data from three large pivotal phase 3 studies, all of which met their co-primary efficacy endpoints. NicOx plans to submit a Marketing Authorization Application (MAA) for naproxcinod to the European Medicines Agency (EMEA) in Q4 2009.
TapeBeat.com, the news and research portal for the serious bio-tech investor in conjunction with the Farseers Group is proud to profile one of the most exciting up and coming biotech companies, MedaSorb Technologies (MSBT.OB), which is perfectly poised to realize exponential growth.
Doctors and clinical investigators from the throughout the Middle East gathered today in Dubai for the opening of the International Osteoporosis Foundation's (IOF) 1st Middle-East and Africa Osteoporosis Meeting.
Memory lapses that occur with normal aging are a source of worry for many who fear Alzheimer's disease. Now a new Mayo Clinic-led study published in the July 16 issue of the New England Journal of Medicine suggests that the carriers of a common genetic risk factor for Alzheimer's disease begin to have memory declines in their mid-50s, far earlier than previously thought.
HMS today announced that it had been awarded two cost containment contracts by the Idaho Department of Health and Welfare, which administers Idaho's Medicaid program. Under the first contract, HMS will to identify third party coverage for casualty and liability claims paid by Idaho Medicaid, and pursue recoveries.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Donald L Kimpel, Po Box 9007, Charlottesville, VA 22906-9007 Ph: () - | Donald L Kimpel, 415 Ray C. Hunt Dr, Ste 2100, Charlottesville, VA 22903 Ph: (434) 243-0223 |
News Archive
NicOx S.A. today announced that a New Drug Application (NDA) for naproxcinod has been submitted to the United States Food and Drug Administration (FDA), seeking approval for an indication for the relief of the signs and symptoms of osteoarthritis (OA). The NDA file contains data from three large pivotal phase 3 studies, all of which met their co-primary efficacy endpoints. NicOx plans to submit a Marketing Authorization Application (MAA) for naproxcinod to the European Medicines Agency (EMEA) in Q4 2009.
TapeBeat.com, the news and research portal for the serious bio-tech investor in conjunction with the Farseers Group is proud to profile one of the most exciting up and coming biotech companies, MedaSorb Technologies (MSBT.OB), which is perfectly poised to realize exponential growth.
Doctors and clinical investigators from the throughout the Middle East gathered today in Dubai for the opening of the International Osteoporosis Foundation's (IOF) 1st Middle-East and Africa Osteoporosis Meeting.
Memory lapses that occur with normal aging are a source of worry for many who fear Alzheimer's disease. Now a new Mayo Clinic-led study published in the July 16 issue of the New England Journal of Medicine suggests that the carriers of a common genetic risk factor for Alzheimer's disease begin to have memory declines in their mid-50s, far earlier than previously thought.
HMS today announced that it had been awarded two cost containment contracts by the Idaho Department of Health and Welfare, which administers Idaho's Medicaid program. Under the first contract, HMS will to identify third party coverage for casualty and liability claims paid by Idaho Medicaid, and pursue recoveries.
› Verified 4 days ago
Daniel S. Strand, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1240 Lee St, Charlottesville, VA 22908 Phone: 434-243-5233 Fax: 434-244-7526 | |
Dr. Numaan F. Malik, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: Lee St Fl 2, Charlottesville, VA 22908 Phone: 434-924-5219 Fax: 434-924-9720 | |
Dr. Asma Shahid Habib, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1204 W Main St, Charlottesville, VA 22903 Phone: 434-924-9119 Fax: 434-924-3300 | |
Amber N. Inofuentes, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1215 Lee St, Charlottesville, VA 22908 Phone: 434-243-4288 Fax: 434-243-7310 | |
Mark Thomas Worthington, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1215 Lee St, Charlottesville, VA 22908 Phone: 434-243-3090 Fax: 434-244-9445 | |
Dr. Emanuel Cirenza, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 590 Peter Jefferson Place, Suite 175, Charlottesville, VA 22911 Phone: 434-982-6900 Fax: 434-982-8420 | |
Warren K. Bolton, M.D. Rheumatology Medicare: Medicare Enrolled Practice Location: Uva Hospital W, Hospital Drive, Charlottesville, VA 22908 Phone: 434-924-1984 Fax: 434-924-5898 |